MedTrace Logo

ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting

NCT06758011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2400

Last updated 2026-02-17

No results posted yet for this study

Summary

This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication starts leaking outside the vein, it can cause damage to the surrounding tissue. Using the ivWatch device may identify leaking fluid before the nurse is able to visually observe the signs or symptoms of the leaking fluid.

Conditions

Interventions

DEVICE

ivWatch

Patients wear ivWatch device at time of already scheduled chemotherapy on study.

Sponsors & Collaborators

  • Roswell Park Cancer Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-17
Primary Completion
2026-01-26
Completion
2026-01-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06758011 on ClinicalTrials.gov